Clinical Trials Logo

Central Nervous System Melanoma clinical trials

View clinical trials related to Central Nervous System Melanoma.

Filter by:
  • Active, not recruiting  
  • Page 1

NCT ID: NCT03025256 Active, not recruiting - Metastatic Melanoma Clinical Trials

Intravenous and Intrathecal Nivolumab in Treating Patients With Leptomeningeal Disease

Start date: May 2, 2018
Phase: Phase 1
Study type: Interventional

This phase I/Ib trial studies the side effects and best dose of intrathecal nivolumab, and how well it works in combination with intravenous nivolumab in treating patients with leptomeningeal disease. Immunotherapy with monoclonal antibodies, such as nivolumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread.